HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Invasive candidiasis — Clinical Guidelines

Overview

Invasive candidiasis (IC) involves the invasion of Candida species into deep tissues or the bloodstream, posing significant risks, particularly in immunocompromised patients such as those with hematological malignancies, hematopoietic stem cell transplant recipients, and intensive care unit (ICU) patients 1.

Diagnosis

Clinical Presentation: Fever, sepsis-like symptoms, organ dysfunction 1 5.

Laboratory Tests: Blood cultures are essential; consider imaging for source identification 1.

Microbiological Confirmation: Positive blood cultures or other sterile site cultures 1.

Risk Stratification: Use scoring systems to identify high-risk patients 1 5.

Management

First-Line Therapy: Echinocandins (e.g., micafungin) are recommended for high-risk patients 1 3.

Adjunctive Treatments: Removal of central venous catheters, infectious diseases consultation 1.

Empirical Therapy: Initiated based on clinical suspicion before microbiological confirmation 3.

Targeted Therapy: Adjusted based on culture and sensitivity results 3.

Special Populations

Pediatrics: Specific guidelines exist for neonates and children, emphasizing prevention and tailored management 2.

Elderly: Increased sensitivity to antifungal agents; dosing adjustments may be necessary 7.

Immunocompromised Patients: Higher risk; close monitoring and multidisciplinary care essential 1 2.

Key Recommendations

First-Line Antifungal Therapy: Use echinocandins as first-line therapy for high-risk patients with invasive candidiasis (Evidence: Strong 1 3).

Non-Pharmacological Interventions: Implement removal of central venous catheters and infectious diseases consultation to reduce mortality (Evidence: Strong 1).

Multimodal Care Bundles: Adopt multimodal interventions including care bundles for improved outcomes in critically ill patients (Evidence: Moderate 1).

Consult Infectious Diseases Specialist: Early consultation with infectious diseases specialists is crucial for optimal management (Evidence: Expert opinion 1).

Consider Risk Stratification Tools: Utilize validated scoring systems to identify patients at high risk for invasive candidiasis (Evidence: Moderate 1 5).

References

1 Keighley C, Cooley L, Morris AJ, Ritchie D, Clark JE, Boan P et al.. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Internal medicine journal 2021. link 2 Tragiannidis A, Tsoulas C, Groll AH. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines. Mycoses 2015. link 3 Maseda E, García-Bernedo CA, Frías I, Navarro JA, Rico J, Iranzo R et al.. A practice-based observational study on the use of micafungin in Surgical Critical Care Units. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2015. link 4 Zaragoza R, Ferrer R, Maseda E, Llinares P, Rodríguez A. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2014. link 5 Zaragoza R, Llinares P, Maseda E, Ferrer R, Rodríguez A. ÉPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Revista espanola de anestesiologia y reanimacion 2013. link 6 Thorpe J, Ahmed I, Hind RE. Intestinal perforation with invasive candidiasis in an immunocompetent adult. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2004. link 7 Lewis KP, Stanley GD. Pharmacology. International anesthesiology clinics 1999. link

Invasive candidiasis